Theodoros Christophides

Dr. Theodoros Christophides

Cardiology, Nicosia General Hospital, Nicosia, Lefkosía, Cyprus
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2007 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CDClaire Dunn
Claire Dunn
Maurizia Rossana BrunettoMaurizia Rossana Brunetto
Maurizia Rossana Brunetto
GRGary Reynolds
Gary Reynolds
Theodoros ChristophidesTheodoros Christophides
Theodoros Christophides
PKPatrick T. Kennedy
Patrick T. Kennedy
MMMala K Maini
Mala K Maini
Hepatitis B virus (HBV) causes chronic infection in more than 350 million people worldwide. It replicates in hepatocytes but is non-cytopathic; liver damage is thought to be immune mediated. Here, we investigated the role of innate immune responses in mediating liver damage in patients with chronic HBV infection. Longitudinal analysis revealed a temporal correlation between flares of liver inflammation and fluctuations in interleukin (IL)-8, interferon (IFN)-α, and natural killer (NK) cell expression of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) directly ex vivo. A cross-sectional study confirmed these findings in patients with HBV-related liver inflammation compared with healthy carriers. Activated, TRAIL-expressing NK cells were further enriched in the liver of patients with chronic HBV infection, while their hepatocytes expressed increased levels of a TRAIL death–inducing receptor. IFN-α concentrations found in patients were capable of activating NK cells to induce TRAIL-mediated hepatocyte apoptosis in vitro. The pathogenic potential of this pathway could be further enhanced by the ability of the IFN-α/IL-8 combination to dysregulate the balance of death-inducing and regulatory TRAIL receptors expressed on hepatocytes. We conclude that NK cells may contribute to liver inflammation by TRAIL-mediated death of hepatocytes and demonstrate that this non-antigen–specific mechanism can be switched on by cytokines produced during active HBV infection.

23 May 2016 in Scientific Reports
Verified
Journal Article
Open access
KSKerstin A. Stegmann
Kerstin A. Stegmann
FRFrancis Robertson
Francis Robertson
NHNavjyot Hansi
Navjyot Hansi
UGUpkar Gill
Upkar Gill
CPCeleste Pallant
Celeste Pallant
MMMala K Maini
Mala K Maini
Natural killer cells (NK) are highly enriched in the human liver, where they can regulate immunity and immunopathology. We probed them for a liver-resident subset, distinct from conventional bone-marrow-derived NK. CXCR6+ NK were strikingly enriched in healthy and diseased liver compared to blood (p < 0.0001). Human hepatic CXCR6+ NK had an immature phenotype (predominantly CD56brightCD16−CD57−), and expressed the tissue-residency marker CD69. CXCR6+ NK produced fewer cytotoxic mediators and pro-inflammatory cytokines than the non-liver-specific CXCR6− fraction. Instead CXCR6+ NK could upregulate TRAIL, a key death ligand in hepatitis pathogenesis. CXCR6 demarcated liver NK into two transcriptionally distinct populations: T-bethiEomeslo(CXCR6−) and T-betloEomeshi(CXCR6+); the latter was virtually absent in the periphery. The small circulating CXCR6+ subset was predominantly T-bethiEomeslo, suggesting its lineage was closer to CXCR6− peripheral than CXCR6+ liver NK. These data reveal a large subset of human liver-resident T-betloEomeshi NK, distinguished by their surface expression of CXCR6, adapted for hepatic tolerance and inducible anti-viral immunity.

12 February 2016 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
Alexandros BriasoulisAlexandros Briasoulis
Alexandros Briasoulis
EAEmmanuel Androulakis
Emmanuel Androulakis
Theodoros ChristophidesTheodoros Christophides
Theodoros Christophides
DTDimitris Tousoulis
Dimitris Tousoulis

1 January 2017 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Closed access
Theodoros ChristophidesTheodoros Christophides
Theodoros Christophides
SKSarosh A Khan
Sarosh A Khan
MAMahmood Ahmad
Mahmood Ahmad
HFHossam Fayed
Hossam Fayed
RBRichard Bogle
Richard Bogle
Lightning strikes are a common and leading cause of morbidity and mortality. Multiple organ systems can be involved, though the effects of the electrical current on the cardiovascular system are one of the main modes leading to cardiorespiratory arrest in these patients. Cardiac effects of lightning strikes can be transient or persistent, and include benign or life-threatening arrhythmias, inappropriate therapies from cardiac implantable electronic devices, cardiac ischaemia, myocardial contusion, pericardial disease, aortic injury, as well as cardiomyopathy with associated ventricular failure. Prolonged resuscitation can lead to favourable outcomes especially in young and previously healthy victims.

1 August 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
CMChrysostomos A. Mavroudis
Chrysostomos A. Mavroudis
BMBikash Majumder
Bikash Majumder
SLSofronis Loizides
Sofronis Loizides
Theodoros ChristophidesTheodoros Christophides
Theodoros Christophides
MJMargaret Johnson
Margaret Johnson
RRRoby D. Rakhit
Roby D. Rakhit

28 February 2024 in Genes
Verified
Journal Article
Open access
PDF file
CKConstantina Koutsofti
Constantina Koutsofti
MIMarios Ioannides
Marios Ioannides
CPChristiana Polydorou
Christiana Polydorou
GPGregory Papagregoriou
Gregory Papagregoriou
AMApostolos Malatras
Apostolos Malatras
Constantinos DeltasConstantinos Deltas
Constantinos Deltas
Inherited cardiomyopathies represent a highly heterogeneous group of cardiac diseases. DNA variants in genes expressed in cardiomyocytes cause a diverse spectrum of cardiomyopathies, ultimately leading to heart failure, arrythmias, and sudden cardiac death. We applied massive parallel DNA sequencing using a 72-gene panel for studying inherited cardiomyopathies. We report on variants in 25 families, where pathogenicity was predicted by different computational approaches, databases, and an in-house filtering analysis. All variants were validated using Sanger sequencing. Familial segregation was tested when possible. We identified 41 different variants in 26 genes. Analytically, we identified fifteen variants previously reported in the Human Gene Mutation Database: twelve mentioned as disease-causing mutations (DM) and three as probable disease-causing mutations (DM?). Additionally, we identified 26 novel variants. We classified the forty-one variants as follows: twenty-eight (68.3%) as variants of uncertain significance, eight (19.5%) as likely pathogenic, and five (12.2%) as pathogenic. We genetically characterized families with a cardiac phenotype. The genetic heterogeneity and the multiplicity of candidate variants are making a definite molecular diagnosis challenging, especially when there is a suspicion of incomplete penetrance or digenic-oligogenic inheritance. This is the first systematic study of inherited cardiac conditions in Cyprus, enabling us to develop a genetic baseline and precision cardiology.